Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 25, 2014The Journal of Infectious DiseasesOpen Access

Assessment of Bone Mineral Density in Tenofovir-Treated Patients With Chronic Hepatitis B: Can the Fracture Risk Assessment Tool Identify Those at Greatest Risk?

View Full Paper
Ask AI
Bookmark
Share

Authors

UGUpkar S. GillQueen Mary University of LondonAZAlexandra ZissimopoulosSASafa Al-Shamma

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gill et al. (2014) studied this question.

synapsesocial.com/papers/6a95be19393bca8e27baedbdhttps://doi.org/10.1093/infdis/jiu471
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hepatology: A home for hepatocellular cancer publications #2009 · 178 citations
  2. 2Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection2012 · 715 citations
  3. 3Reasons to consider earlier treatment of chronic HBV infections2011 · 115 citations
  4. 4Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis1998 · 244 citations
  5. 5Bone Strength at Clinically Relevant Sites Displays Substantial Heterogeneity and Is Best Predicted From Site-Specific Bone Densitometry2002 · 111 citations